This month, DFC’s Chief Operating Officer David Marchick and other senior officials traveled to South Africa and India to advance the agency’s investments in the global health sector and bolster COVID-19 vaccine manufacturing capacity.
Access to safe and effective vaccines is an imperative for ending the global pandemic. Under President Biden’s leadership, DFC is targeting support for vaccines in developing countries, and the agency’s investments are projected to produce nearly 2 billion COVID-19 vaccine doses by the end of 2022. By advancing work in the vaccine sector, DFC aims to lead the global vaccination effort and save lives across the developing world.
Building Regional Vaccine Capacity in the Indo Pacific
DFC and Biological E. Limited announced the expansion of Biological E.’s vaccine manufacturing facility in Hyderabad, which will advance President Biden’s Quad Vaccine Partnership and accelerate the end of the pandemic.